EZSolution™ Lapatinib Ditosylate | 2807

A 10 mM (10 mg in 1080 µl) of the EGFR inhibitor Lapatinib ditosylate (Cat. No.1624) in anhydrous DMSO.

Lapatinib is a potent inhibitor of EGFR kinase (Ki = 3 nM), ErbB-2 kinase (Ki = 13 nM), ErbB-4 kinase (Ki = 347 nM). Lapatinib can restore tamoxifen sensitivity in tamoxifen-resistant, ER-positive breast cancer models.

2807 | EZSolution™ Lapatinib Ditosylate DataSheet

Alternate Name/Synonyms: N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-quinazolinamine bis(4-methylbenzenesulfonate) ditosylate; GW-572016F ditosylate;Tykerb ditosylate

Appearance: Liquid

Formulation: 10 mM solution in DMSO

CAS Number: 388082-78-8

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: No

Molecular Formula: C₂₉H₂₆ClFN₄O₄S.2C₇H₈O₃S

Molecular Weight: 925.46

Cell-Permeable?: Yes

Purity: ≥98% by HPLC

Solubilities: N/A

Handling: Protect from air and moisture

Country of Origin: USA

Tag Line: A potent EGFR inhibitor

MDL Number: MFCD18904381

PubChem CID: 9941095

SMILES: CC1=CC=C(C=C1)S(=O)(=O)O.CC1=CC=C(C=C1)S(=O)(=O)O.CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl

InChi: InChI=1S/C29H26ClFN4O4S.2C7H8O3S/c1-40(36,37)12-11-32-16-23-7-10-27(39-23)20-5-8-26-24(14-20)29(34-18-33-26)35-22-6-9-28(25(30)15-22)38-17-19-3-2-4-21(31)13-19;2*1-6-2-4-7(5-3-6)11(8,9)10/h2-10,13-15,18,32H,11-12,16-17H2,1H3,(H,33,34,35);2*2-5H,1H3,(H,8,9,10)

InChi Key: UWYXLGUQQFPJRI-UHFFFAOYSA-N